Worth a shot: Immunotherapy effective in severe eczema

The case report adds to evidence in support of subcutaneous allergy therapy

Subcutaneous allergen immunotherapy appears to have reduced a patient’s symptoms of severe eczema, according to a new case study.

Before immunotherapy, the 48-year-old patient with a history of severe eczema since childhood, scored 79.4 on the Scoring Atopic Dermatitis (SCORAD) index — well into the severe range.

Previous therapies had been ineffective, including topical corticosteroids and calcineurin inhibitors, as well as PRN systemic corticosteroids.

"We conducted skin testing and found the man was allergic to dust mites, weeds, trees, grasses, mould, cats and dogs," said allergist Dr Anita Wasan, co-author of the case report.

"Because his allergies could all be treated with allergy shots, we thought treating his allergies might also benefit his eczema.

"After one year, he reported significant benefit to his symptoms, which was great news. And once he reached a